Rosetta Genomics Files for Chapter 7 Bankruptcy

Sep

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care.

Oct

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

Menu

Rosetta Genomics Files for Chapter 7 Bankruptcy

To read the full story....

Breaking News

Biovica Files FDA 510(k) Submission for Breast Cancer Treatment Response Assay

Genetron, CStone Launch Clinical Trial to Develop CDx for Cancer Drug Avapritinib

Natera Cancer Liquid Biopsy Test Coverage to Expand Under New Draft LCD

Fulgent Inks $125M Equity Distribution Agreement With Piper Sandler

FDA Grants Emergency Use Authorization for Jiangsu Well Biotech Coronavirus Antibody Test

BARDA Awards $5.4M to Luminex for Expanded Respiratory Panel With Coronavirus Target

Featured White Papers

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

What's Popular?

United Airlines Launches COVID-19 Testing Program for Travelers to Hawaii

BARDA Awards $5.4M to Luminex for Expanded Respiratory Panel With Coronavirus Target

Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test

BioReference Settles False Claims, Kickback Allegations for $11.5M

BGI Genomics Gets CE Mark for Multiplexed SARS-CoV-2, Influenza Tests

Sponsorships